Discretionary Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting, 46444-46445 [2014-18737]
Download as PDF
46444
Federal Register / Vol. 79, No. 153 / Friday, August 8, 2014 / Notices
percent; Hba1c greater than or equal to
8 percent and less than or equal to 9
percent; and Hba1c greater than 9
percent. Health centers will report one
category, Hba1c greater than 9 percent.
Likely Respondents: The respondents
will be HRSA BPHC Health Center
Program grantees and look-alikes.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
Number of
respondents
Form name
Universal Report ..................................................................
Grant Report ........................................................................
Total ..............................................................................
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Dated: August 1, 2014.
Jackie Painter,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–18736 Filed 8–7–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Discretionary Advisory Committee on
Heritable Disorders in Newborns and
Children; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463, codified at 5 U.S.C.
App.), notice is hereby given of the
following meeting:
Name: Discretionary Advisory
Committee on Heritable Disorders in
Newborns and Children
Dates and Times: September 11, 2014,
9:30 a.m. to 4:30 p.m.
September 12, 2014, 9:00 a.m. to 3:00
p.m.
Place: Webinar and In-Person,
National Institute of Health, Natcher
Conference Center (Building 45), 9000
Rockville Pike, Bethesda, MD 20892.
Status: The meeting will be open to
the public with attendance limited to
VerDate Mar<15>2010
16:51 Aug 07, 2014
Jkt 232001
1,302
499
1,801
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
Total Estimated Annualized Burden
Hours:
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
1
1
........................
1302
499
........................
82
18
........................
space availability. Participants also have
the option of viewing the meeting via
webinar. Whether attending in-person
or via webinar, all participants must
register for the meeting at https://www.
blsmeetings.net/ACHDNCSeptember
2014/. The registration deadline is
Thursday, August 28, 2014, 11:59 p.m.
Eastern Time. If there are technical
problems gaining access to the Web site,
please contact Anthony Rodell, Director
of Client Relations, at arodell@Seamon
Corporation.com.
Purpose: The Discretionary Advisory
Committee on Heritable Disorders in
Newborns and Children (Committee), as
authorized by Public Health Service Act
(PHS), 42 U.S.C. 217a: Advisory
councils or committees, was established
to advise the Secretary of the
Department of Health and Human
Services about the development of
newborn screening activities,
technologies, policies, guidelines, and
programs for effectively reducing
morbidity and mortality in newborns
and children having, or at risk for,
heritable disorders. In addition, the
Committee’s recommendations
regarding additional conditions/
inherited disorders for screening that
have been adopted by the Secretary are
included in the Recommended Uniform
Screening Panel and constitute part of
the comprehensive guidelines
supported by the Health Resources and
Services Administration. Pursuant to
section 2713 of the Public Health
Service Act, codified at 42 U.S.C.
300gg–13, non-grandfathered health
plans are required to cover screenings
included in the HRSA-supported
comprehensive guidelines without
charging a co-payment, co-insurance, or
deductible for plan years (i.e., policy
years) beginning on or after the date that
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Total burden
hours
106,764
8,982
115,746
is 1 year from the Secretary’s adoption
of the condition for screening.
Agenda: The meeting will include: (1)
Presentations from the Newborn
Screening Translational Research
Network and the Region 4 Genetics
Collaborative on long-term follow up
activities as they relate to newborn
screening; (2) an update on the
Mucopolysaccharidosis 1 (MPS–1)
condition review; (3) presentations and
discussion on national activities
addressing timeliness of newborn
screening; (4) a presentation on the
Region 4 Stork (R4S) database that
facilitates the clinical validation of
cutoff target ranges for metabolic
disorders by tandem mass spectrometry;
(5) a presentation of the National
Committee on Vital and Health
Statistics’ recommendations regarding
the adoption of electronic standards for
public health information exchanges; (6)
a presentation on the Clinical
Laboratory Improvement Amendments
(CLIA) Program and Health Insurance
Portability and Accountability Act
(HIPAA) Privacy Rule—Patients’ Access
to Test Reports; and (7) updates from
the Laboratory Standards and
Procedures, Follow-up and Treatment,
and Education and Training
subcommittees. Tentatively, the
Committee is expected to review and/or
vote on recommendations to the
Secretary regarding educational
activities that emphasize
succinylacetone as the best marker for
Tyrosinemia Type I screening, a
condition on the Recommended
Uniform Screening Panel (RUSP). This
tentative vote does not involve any
proposed addition of a condition to the
RUSP.
Agenda items are subject to change as
necessary or appropriate. The agenda,
webinar information, Committee Roster,
E:\FR\FM\08AUN1.SGM
08AUN1
Federal Register / Vol. 79, No. 153 / Friday, August 8, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Charter, presentations, and other
meeting materials are located on the
Advisory Committee’s Web site at
https://www.hrsa.gov/advisory
committees/mchbadvisory/heritable
disorders.
Public Comments: Members of the
public may present oral comments and/
or submit written comments. Comments
are part of the official Committee record.
The public comment period is
tentatively scheduled for September 11,
2014. Advance registration is required
to present oral comments and/or submit
written comments at https://www.bls
meetings.net/ACHDNCSeptember2014/.
The registration deadline is Thursday,
August 28, 2014, 11:59 p.m. Eastern
Time. Written comments must be
received by the deadline in order to be
included in the September meeting
briefing book. Written comments should
identify the individual’s name, address,
email, telephone number, professional
or business affiliation, type of expertise
(i.e., parent, researcher, clinician, public
health, etc.), and the topic/subject
matter of comments. To ensure that all
individuals who have registered to make
oral comments can be accommodated,
the allocated time may be limited.
Individuals who are associated with
groups or have similar interests may be
requested to combine their comments
and present them through a single
representative. No audiovisual
presentations are permitted. For
additional information or questions on
public comments, please contact Lisa
Vasquez, Maternal and Child Health
Bureau, Health Resources and Services
Administration; email: lvasquez@
hrsa.gov.
For More Information Contact:
Anyone interested in obtaining other
relevant information should contact
Debi Sarkar, Maternal and Child Health
Bureau, Health Resources and Services
Administration, Room 18A–19,
Parklawn Building, 5600 Fishers Lane,
Rockville, Maryland 20857; email:
dsarkar@hrsa.gov.
More information on the Advisory
Committee is available at https://www.
hrsa.gov/advisorycommittees/mchb
advisory/heritabledisorders.
Dated: August 1, 2014.
Jackie Painter,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–18737 Filed 8–7–14; 8:45 am]
BILLING CODE 4165–15–P
VerDate Mar<15>2010
16:51 Aug 07, 2014
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Advisory Committee on Rural
Health and Human Services; Notice of
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), announcement is
made of the following National
Advisory body scheduled to meet
during the month of September 2014.
The National Advisory Committee on
Rural Health and Human Services will
convene its seventy sixth meeting in the
time and place specified below:
Name: National Advisory Committee
on Rural Health and Human Services.
Dates and Time: September 24, 2014,
8:45 a.m.–5:00 p.m. September 25, 2014,
8:30 a.m.–5:30 p.m. September 26, 2014,
8:30 a.m.–11:00 a.m.
Place: Avera eHelm, 4500 N Lewis
Ave, Sioux Falls, SD 57104, (605) 322–
4669.
Status: The meeting will be open to
the public.
Purpose: The National Advisory
Committee on Rural Health and Human
Services provides counsel and
recommendations to the Secretary with
respect to the delivery, research,
development, and administration of
health and human services in rural
areas.
Agenda: Wednesday morning, at 8:45
a.m., the meeting will be called to order
by the Chairperson of the Committee:
The Honorable Ronnie Musgrove. The
Committee will assess how telehealth
coverage opportunities in rural areas are
affected by the Affordable Care Act. The
Committee will also examine the issue
of rural domestic violence. The day will
conclude with a period of public
comment at approximately 4:45 p.m.
Thursday morning at approximately
8:30 a.m., the Committee will break into
Subcommittees and depart for site visits
to health care and human services
providers in South Dakota and
Minnesota. Subcommittees will visit the
Pipestone County Medical Center and
the Good Samaritan Society in
Pipestone, Minnesota, and the Horizon
Health Clinic in Howard, South Dakota.
The day will conclude at the Avera
eHelm with a period of public comment
at approximately 5:15 p.m.
Friday morning at 8:30 a.m., the
Committee will meet to summarize key
findings and develop a work plan for
the next quarter and the following
meeting.
FOR FURTHER INFORMATION CONTACT:
Steve Hirsch, MSLS, Executive
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
46445
Secretary, National Advisory Committee
on Rural Health and Human Services,
Health Resources and Services
Administration, Parklawn Building,
17W29–C, 5600 Fishers Lane, Rockville,
Maryland 20857, telephone (301) 443–
0835, or fax (301) 443–2803.
Persons interested in attending any
portion of the meeting should contact
Catherine Fontenot at the Office of Rural
Health Policy (ORHP) via telephone at
(301) 945–0897or by email at cfontenot@
hrsa.gov. The Committee meeting
agenda will be posted on the
Committee’s Web site at https://www.
hrsa.gov/advisorycommittees/rural/.
Dated: August 1, 2014.
Jackie Painter,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–18735 Filed 8–7–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request
The Social Security Administration
(SSA)—National Institutes of Health
(NIH) Collaboration to Improve the
Disability Determination Process:
Calibration II, Predictive Validity
Testing & Validation of Item Response
Theory-Computer Adaptive Testing
Tools (IRT–CAT) (CC)
SUMMARY: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on April 22, 2014,
page 22507 and allowed 60-days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The Clinical
Center, National Institutes of Health,
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
E:\FR\FM\08AUN1.SGM
08AUN1
Agencies
[Federal Register Volume 79, Number 153 (Friday, August 8, 2014)]
[Notices]
[Pages 46444-46445]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18737]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Discretionary Advisory Committee on Heritable Disorders in
Newborns and Children; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463, codified at 5 U.S.C. App.), notice is
hereby given of the following meeting:
Name: Discretionary Advisory Committee on Heritable Disorders in
Newborns and Children
Dates and Times: September 11, 2014, 9:30 a.m. to 4:30 p.m.
September 12, 2014, 9:00 a.m. to 3:00 p.m.
Place: Webinar and In-Person, National Institute of Health, Natcher
Conference Center (Building 45), 9000 Rockville Pike, Bethesda, MD
20892.
Status: The meeting will be open to the public with attendance
limited to space availability. Participants also have the option of
viewing the meeting via webinar. Whether attending in-person or via
webinar, all participants must register for the meeting at https://www.blsmeetings.net/ACHDNCSeptember2014/. The registration deadline is
Thursday, August 28, 2014, 11:59 p.m. Eastern Time. If there are
technical problems gaining access to the Web site, please contact
Anthony Rodell, Director of Client Relations, at
arodell@SeamonCorporation.com.
Purpose: The Discretionary Advisory Committee on Heritable
Disorders in Newborns and Children (Committee), as authorized by Public
Health Service Act (PHS), 42 U.S.C. 217a: Advisory councils or
committees, was established to advise the Secretary of the Department
of Health and Human Services about the development of newborn screening
activities, technologies, policies, guidelines, and programs for
effectively reducing morbidity and mortality in newborns and children
having, or at risk for, heritable disorders. In addition, the
Committee's recommendations regarding additional conditions/inherited
disorders for screening that have been adopted by the Secretary are
included in the Recommended Uniform Screening Panel and constitute part
of the comprehensive guidelines supported by the Health Resources and
Services Administration. Pursuant to section 2713 of the Public Health
Service Act, codified at 42 U.S.C. 300gg-13, non-grandfathered health
plans are required to cover screenings included in the HRSA-supported
comprehensive guidelines without charging a co-payment, co-insurance,
or deductible for plan years (i.e., policy years) beginning on or after
the date that is 1 year from the Secretary's adoption of the condition
for screening.
Agenda: The meeting will include: (1) Presentations from the
Newborn Screening Translational Research Network and the Region 4
Genetics Collaborative on long-term follow up activities as they relate
to newborn screening; (2) an update on the Mucopolysaccharidosis 1
(MPS-1) condition review; (3) presentations and discussion on national
activities addressing timeliness of newborn screening; (4) a
presentation on the Region 4 Stork (R4S) database that facilitates the
clinical validation of cutoff target ranges for metabolic disorders by
tandem mass spectrometry; (5) a presentation of the National Committee
on Vital and Health Statistics' recommendations regarding the adoption
of electronic standards for public health information exchanges; (6) a
presentation on the Clinical Laboratory Improvement Amendments (CLIA)
Program and Health Insurance Portability and Accountability Act (HIPAA)
Privacy Rule--Patients' Access to Test Reports; and (7) updates from
the Laboratory Standards and Procedures, Follow-up and Treatment, and
Education and Training subcommittees. Tentatively, the Committee is
expected to review and/or vote on recommendations to the Secretary
regarding educational activities that emphasize succinylacetone as the
best marker for Tyrosinemia Type I screening, a condition on the
Recommended Uniform Screening Panel (RUSP). This tentative vote does
not involve any proposed addition of a condition to the RUSP.
Agenda items are subject to change as necessary or appropriate. The
agenda, webinar information, Committee Roster,
[[Page 46445]]
Charter, presentations, and other meeting materials are located on the
Advisory Committee's Web site at https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Public Comments: Members of the public may present oral comments
and/or submit written comments. Comments are part of the official
Committee record. The public comment period is tentatively scheduled
for September 11, 2014. Advance registration is required to present
oral comments and/or submit written comments at https://www.blsmeetings.net/ACHDNCSeptember2014/. The registration deadline is
Thursday, August 28, 2014, 11:59 p.m. Eastern Time. Written comments
must be received by the deadline in order to be included in the
September meeting briefing book. Written comments should identify the
individual's name, address, email, telephone number, professional or
business affiliation, type of expertise (i.e., parent, researcher,
clinician, public health, etc.), and the topic/subject matter of
comments. To ensure that all individuals who have registered to make
oral comments can be accommodated, the allocated time may be limited.
Individuals who are associated with groups or have similar interests
may be requested to combine their comments and present them through a
single representative. No audiovisual presentations are permitted. For
additional information or questions on public comments, please contact
Lisa Vasquez, Maternal and Child Health Bureau, Health Resources and
Services Administration; email: lvasquez@hrsa.gov.
For More Information Contact: Anyone interested in obtaining other
relevant information should contact Debi Sarkar, Maternal and Child
Health Bureau, Health Resources and Services Administration, Room 18A-
19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857;
email: dsarkar@hrsa.gov.
More information on the Advisory Committee is available at https://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders.
Dated: August 1, 2014.
Jackie Painter,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2014-18737 Filed 8-7-14; 8:45 am]
BILLING CODE 4165-15-P